Medline, Inc. MDLN Laboratory and Diagnostics — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medline, Inc. 's laboratory and diagnostics — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medline, Inc. 's laboratory and diagnostics — net sales?
- Medline, Inc. (MDLN) reported laboratory and diagnostics — net sales of $293M in Q1 2026.
- How has Medline, Inc. 's laboratory and diagnostics — net sales changed year-over-year?
- Medline, Inc. 's laboratory and diagnostics — net sales increased by 0.7% year-over-year, from $291M to $293M.
- What does laboratory and diagnostics — net sales mean?
- This metric represents the total revenue generated from the sale of laboratory equipment, diagnostic testing supplies, and related clinical diagnostic products. It reflects the company's market penetration and demand within the clinical diagnostics and pathology testing sectors across various healthcare settings. This revenue stream is a key indicator of the company's ability to capture market share in the essential diagnostic testing supply chain.